Insulin therapy for the critically ill patient

Area of Science:

• Critical Care Medicine
• Endocrinology
• Metabolic Disorders

Background:

• Critically ill patients in intensive care units (ICUs) for over 5 days face high risks of mortality and morbidity.
• Hyperglycemia (high blood sugar) is common in ICU patients, often presumed to be an adaptive response to critical illness.
• This hyperglycemia may instead contribute to complications like sepsis, organ failure, and prolonged ICU stays.

Purpose of the Study:

• To investigate the hypothesis that hyperglycemia worsens critical illness outcomes.
• To evaluate the effects of intensive insulin therapy aimed at maintaining normoglycemia (normal blood sugar) in surgical ICU patients.
• To determine if strict blood glucose control improves patient outcomes.

Main Methods:

• A large study (N=1548) involving ventilated, surgical ICU patients.
• Random assignment to either intensive insulin therapy (blood glucose 80-110 mg/dL) or conventional treatment (insulin only if glucose > 200 mg/dL).
• Use of a titration algorithm to manage insulin infusion for intensive therapy.

Main Results:

• Intensive insulin therapy led to a 43% reduction in ICU mortality risk and a 34% reduction in hospital mortality.
• A 46% reduction in severe infections and a 35% decrease in prolonged antibiotic use were observed.
• Prevention of excessive inflammation was noted; logistic regression suggested blood glucose control, not insulin itself, drove benefits.

Conclusions:

• Maintaining normoglycemia through intensive insulin therapy using a titration algorithm improves outcomes in surgical ICU patients.
• Blood glucose control is a critical factor in reducing mortality, infection, and inflammation in critical illness.
• Further research is needed to confirm applicability in medical ICUs and general hospital settings.